214 related articles for article (PubMed ID: 24285100)
1. New insights in risk stratification of differentiated thyroid cancer.
Papaleontiou M; Haymart MR
Curr Opin Oncol; 2014 Jan; 26(1):1-7. PubMed ID: 24285100
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors in Differentiated Thyroid Cancer Revisited.
Glikson E; Alon E; Bedrin L; Talmi YP
Isr Med Assoc J; 2017 Feb; 19(2):114-118. PubMed ID: 28457063
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
4. The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988-2008).
Wei WJ; Lu ZW; Wen D; Liao T; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
World J Surg; 2018 Jun; 42(6):1762-1771. PubMed ID: 29185020
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
6. The impact of age on thyroid cancer staging.
Kazaure HS; Roman SA; Sosa JA
Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):330-334. PubMed ID: 30048260
[TBL] [Abstract][Full Text] [Related]
7. NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.
Klein Hesselink EN; van der Horst-Schrivers ANA; van der Horst ICC; Bakker SJL; Muller Kobold AC; Brouwers AH; de Bock GH; Gietema JA; Dullaart RPF; Links TP; Lefrandt JD
Clin Biochem; 2017 Aug; 50(12):696-702. PubMed ID: 28242284
[TBL] [Abstract][Full Text] [Related]
8. Survival and death causes in differentiated thyroid carcinoma.
Eustatia-Rutten CF; Corssmit EP; Biermasz NR; Pereira AM; Romijn JA; Smit JW
J Clin Endocrinol Metab; 2006 Jan; 91(1):313-9. PubMed ID: 16263822
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System.
Pires BP; Alves PA; Bordallo MA; Bulzico DA; Lopes FP; Farias T; Dias F; Lima RA; Santos Gisler IC; Coeli CM; Carvalhaes de Oliveira RV; Corbo R; Vaisman M; Vaisman F
Thyroid; 2016 Oct; 26(10):1480-1487. PubMed ID: 27540892
[TBL] [Abstract][Full Text] [Related]
10. Risk and prognostic factors for differentiated thyroid cancer.
Duntas L; Grab-Duntas BM
Hell J Nucl Med; 2006; 9(3):156-62. PubMed ID: 17160155
[TBL] [Abstract][Full Text] [Related]
11. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
12. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Perrier ND; Brierley JD; Tuttle RM
CA Cancer J Clin; 2018 Jan; 68(1):55-63. PubMed ID: 29092098
[TBL] [Abstract][Full Text] [Related]
13. New insights into the management of differentiated thyroid carcinoma in children and adolescents (Review).
Zanella AB; Scheffel RS; Weinert L; Dora JM; Maia AL
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33649842
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy.
Park S; Kim WG; Song E; Oh HS; Kim M; Kwon H; Jeon MJ; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Apr; 27(4):524-530. PubMed ID: 27869547
[TBL] [Abstract][Full Text] [Related]
15. The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thyroid cancer in patients with thyroid nodules: A systematic review and meta-analysis.
Su A; Zhao W; Wu W; Wei T; Ruan M; Li Z; Zhu J
Am J Surg; 2020 Sep; 220(3):634-641. PubMed ID: 31955813
[TBL] [Abstract][Full Text] [Related]
16. The Usefulness of Preoperative Thyroid-Stimulating Hormone for Predicting Differentiated Thyroid Microcarcinoma.
Shi RL; Liao T; Qu N; Liang F; Chen JY; Ji QH
Otolaryngol Head Neck Surg; 2016 Feb; 154(2):256-62. PubMed ID: 26598500
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of cervical lymph nodes in differentiated thyroid cancer.
Fritze D; Doherty GM
Otolaryngol Clin North Am; 2010 Apr; 43(2):285-300, viii. PubMed ID: 20510715
[TBL] [Abstract][Full Text] [Related]
18. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.
Gao Y; Qu N; Zhang L; Chen JY; Ji QH
Tumour Biol; 2016 Jun; 37(6):7453-9. PubMed ID: 26678888
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review.
Wiseman SM; Hicks WL; Chu QD; Rigual NR
Surg Oncol; 2002 Nov; 11(3):137-42. PubMed ID: 12356509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]